Percutaneous Revascularization Devices Market Snapshot 2024-2028
Overview
Valued at ~$1.45 billion in 2023, the percutaneous revascularization devices market is
projected to reach ~$4.19 billion by 2028, increasing at a CAGR of 23.6% over
the 2023-2028 forecast period. This Market Snapshot is part of LSI’s Market Intelligence platform, your
one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and
deal-tracking, curated insights, and more.
Percutaneous revascularization devices are catheter-based tools used to treat atherosclerosis, a condition where
arteries narrow and restrict blood flow. These devices work by modifying plaque within the vessel, which helps
widen the artery and improve blood circulation. These devices are one of many solutions available to prepare and
revascularize occluded vessels. This analysis focuses on catheter-based revascularization devices, excluding angioplasty
balloons,
another commonly used treatment option.
Products included within the scope of this analysis include:
Directional atherectomy
Laser atherectomy
Orbital atherectomy
Laser atherectomy
Intravascular lithotripsy (IVL)
This Market Snapshot is intended to provide a high-level overview of the global market for percutaneous
revascularization devices, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups
Percutaneous Revascularization Devices Market Snapshot Summary
| Snapshot Aspect | Data and Details |
| Base Year for Estimate | 2023 |
| Forecast Period | 2023 - 2028 |
| Market Size in 2023 | $1.45 billion |
| CAGR | 23.6% |
| Projected Market Size in 2028 | $4.19 billion |
Percutaneous Revascularization Devices Market Insights
The percutaneous revascularization devices market has experienced substantial growth, driven by innovations like
IVL, which has become an essential technique for managing calcified lesions. The adoption of IVL—particularly
the Shockwave Medical IVL device—has significantly reshaped the market, with Shockwave becoming the largest
supplier in the atherectomy/plaque modification device market by revenue in 2022. This market has expanded to
$1.45 billion in 2023, a nearly three-fold increase since Shockwave’s entry in 2016.
The shift from traditional atherectomy devices to IVL has significantly changed the market’s pricing dynamics,
as IVL catheters, such as the Shockwave device, are priced significantly higher—up to four times more than
conventional atherectomy catheters. This shift reflects the growing clinical acceptance of IVL for plaque
modification, positioning it as a dominant solution in the revascularization devices market.
Competitive Landscape
The full Market Snapshot includes a robust analysis of the competitive landscape for the percutaneous
revascularization devices market. This includes estimated market revenue and market share for key players, such
as Shockwave Medical, Cardiovascular Systems, and Medtronic.
Select Market Events
| Company | Date | Type | Event |
|
Johnson & Johnson
|
5/2024 | M&A | J&J completed its acquisition of Shockwave Medical, the current market leader for atherectomy devices. |
Key Companies Covered
Amplitude Vascular Systems
Boston Scientific
Cardiovascular Systems
FastWave Medical
Johnson & Johnson
Rex Medical
Shockwave Medical
Sonosemi Medical
Vantis Vascular
